Pediatric neuroblastoma patients without MYCN amplification and with lower E2F1 expression levels had significantly longer event free survival and overall survival in GSE16476, GSE85047 and E-MTAB-1781 datasets (Fig. 5a and supplementary Fig. 2a). Here, E2F1 is linked to neuroblastoma.